The story has been refreshed with the latest market price action and a revised headline. Elon Musk said Wednesday that mRNA technology could fundamentally change how diseases are treated, a shift that would make medicine more of

Moderna has now swung violently in both directions for three straight sessions on the same unchanged clinical news, and the options chain hints at why this whipsaw is far from over.

Doctors and patients are excited about the possible breakthrough, but some analysts believe there’s too much hype.

Moderna stock surged on Phase 3 mRNA cancer vaccine results with Merck, breaking key moving averages and hitting record RSI.

Moderna dropped 10% after Wednesday's surge, crypto stocks rallied on Trump's legislation call, and Walmart fell 6% despite raising guidance Thursday.

Moderna and Merck’s first-of-its-kind cancer vaccine helped prevent the return of melanoma in a late-stage trial, and shares of both companies soared.

The combined drug works by nudging the body’s own immune system to make proteins that attack and destroy melanoma cells